Alnylam Pharmaceuticals
ALNY
#637
Rank
NZ$56.75 B
Marketcap
$438.38
Share price
-0.02%
Change (1 day)
79.71%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of December 2024 : NZ$0.11 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has NZ$0.11 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-NZ$0.35 Billion40%
2022-12-31$-NZ$0.25 Billion-128.94%
2021-12-31$NZ$0.86 B-38.86%
2020-12-31$NZ$1.40 B-34.07%
2019-12-31$NZ$2.13 B10.06%
2018-12-31$NZ$1.94 B-21.96%
2017-12-31$NZ$2.48 B87.22%
2016-12-31$NZ$1.32 B-28.11%
2015-12-31$NZ$1.84 B54.64%
2014-12-31$NZ$1.19 B263.23%
2013-12-31$NZ$0.32 B101.89%
2012-12-31$NZ$0.16 B7.78%
2011-12-31$NZ$0.15 B-26.29%
2010-12-31$NZ$0.20 B-16.29%
2009-12-31$NZ$0.24 B-29.65%
2008-12-31$NZ$0.34 B33.96%
2007-12-31$NZ$0.26 B-8.94%
2006-12-31$NZ$0.28 B215.93%
2005-12-31$NZ$90.38 M39.78%
2004-12-31$NZ$64.66 M-257.4%
2003-12-31$-NZ$41.09 Million362.8%
2002-12-31$-NZ$8.88 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$98.34 M-16.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$51.48 B 43,653.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.14 B 1,720.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.46 B 1,991.91%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.15 B 29.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$77.39 B 65,673.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$137.24 B 116,540.23%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$10.03 B 8,426.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel